SLQT — what changed in the latest 10-Q
A section-by-section comparison of SLQT's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-05-05 vs the prior 10-Q · 2026-02-05
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +45 | −62 | ~42 | 68 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~3 | 0 |
| Controls & procedures | Text added/removed | 0 | 0 | ~1 | 2 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | +2 | 0 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-05-05
Total term premiums increased 1% for the three months ended March 31, 2026, compared to the three months ended March 31, 2025, due to a 1% increase in the average premium per policy sold. Final expense premiums decreased 1% for the three months ended March 31, 2026, compared to the three months ende…
primarily attributable to new external agents and, to a lesser extent, flex agents onboarded from the Senior segment during the nine months ended March 31, 2026, both of which were less productive than our tenured agents.
Three Months Ended March 31, 2026 and 2025–Commission and other services revenue increased $12.8 million, or 6%, for the three months ended March 31, 2026, primarily due to a $28.6 million increase in Senior commissions revenue, a $2.1 million increase in Life revenue, partially offset by a $15.2 mi…
Nine Months Ended March 31, 2026 and 2025–Commission and other services revenue decreased $7.5 million, or 1%, for the nine months ended March 31, 2026, primarily due to a $19.0 million decrease in other Senior revenue, partially offset by a $13.2 million increase in Life revenue. The decrease in ot…
Drug Inflation Rebate Program under the Inflation Reduction Act, which are reported as a reduction to cost of goods sold—pharmacy revenue.
Text removed vs the prior filing · source: 10-Q · 2026-02-05
Three Months Ended December 31,Six Months Ended December 31,
Three Months Ended December 31,Six Months Ended December 31,
Three Months Ended December 31,Six Months Ended December 31,
Three Months Ended December 31,Six Months Ended December 31,
Three Months Ended December 31,Six Months Ended December 31,
Other information
Text added vs the prior filing · source: 10-Q · 2026-05-05
On March 2, 2026, Sarah Anderson, Executive Vice President of Pharmacy, adopted a Rule 10b5-1 trading arrangement for the sale of up to 30,000 shares of our common stock, subject to certain conditions. The arrangement’s expiration date is May 31, 2027.
On February 17, 2026, Denise Devine, a member of the Company’s Board of Directors, adopted a Rule 10b5-1 trading arrangement for the sale of up to 4,000 shares of our common stock, subject to certain conditions. The arrangement’s expiration date is February 12, 2027.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice